Connect with others like you for support and answers to your questions in the
Transplants support group
on Mayo Clinic Connect, a patient community.
Transplants Discussions
Polycystic kidney disease (PKD). National Institute of Diabetes and Digestive and Kidney Diseases. https://www.niddk.nih.gov/health-information/kidney-disease/polycystic-kidney-disease. Accessed May 6, 2020.
Chapman AB, et al. Autosomal dominant polycystic kidney disease (ADPKD): Treatment. https://www.uptodate.com/contents/search. Accessed May 6, 2020.
Polycystic kidney disease. American Kidney Fund. https://www.kidneyfund.org/kidney-disease/other-kidney-conditions/polycystic-kidney-disease.html. Accessed May 6, 2020.
Bennett WM, et al. Autosomal dominant polycystic kidney disease (ADPKD): Extrarenal manifestations. https://www.uptodate.com/contents/search. Accessed May 6, 2020.
Polycystic kidney disease. National Kidney Foundation. https://www.kidney.org/atoz/content/polycystic. Accessed May 6, 2020.
Torres VE, et al. Autosomal dominant polycystic kidney disease (ADPKD) in adults: Epidemiology, clinical presentation, and diagnosis. https://www.uptodate.com/contents/search. Accessed May 6, 2020.
Albert CM, et al. Autosomal dominant polycystic kidney disease: The changing face of clinical management. The Lancet. 2015; doi:10.1016/S0140-6736(15)60907-2.
Rossetti S, et al. Identification of gene mutations in autosomal dominant polycystic kidney disease through targeted resequencing. Journal of the American Society of Nephrology. 2012; doi:10.1681/ASN.2011101032.
Torres VE, et al. Strategies targeting cAMP signaling in the treatment of polycystic kidney disease. Journal of the American Society of Nephrology. 2014; doi:10.1681/ASN.2013040398.
Shoaf SE, et al. Pharmacokinetics and pharmacodynamics of tolvaptan in autosomal dominant polycystic kidney disease: Phase 2 trials for dose selection in the pivotal phase 3 trial. The Journal of Clinical Pharmacology. 2017; doi:10.1002/jcph.880.
Hogan MC, et al. Somatostatin analog therapy for severe polycystic liver disease: Results after 2 years. Nephrology Dialysis Transplantation. 2012; doi:10.1093/ndt/gfs152.
AskMayoExpert. Autosomal dominant polycystic kidney disease (ADPKD). Mayo Clinic; 2020.
Warner KJ. Allscripts EPSi. Mayo Clinic. Feb. 5, 2020.
Chebib FT, et al. Autosomal dominant polycystic kidney disease: Core curriculum 2016. American Journal of Kidney Diseases. 2016; doi:10.1053/j.ajkd.2015.07.037.
Chebib FT, et al. Recent advances in the management of autosomal dominant polycystic kidney disease. Clinical Journal of the American Society of Nephrology. 2018; doi:10.2215/CJN.03960318.
Chebib FT, et al. A practical guide for treatment of rapidly progressive ADPKD with tolvaptan. Journal of the American Society of Nephrology. 2018; doi:10.1681/ASN.2018060590.
Chebib FT (expert opinion). Mayo Clinic. July 10, 2020.
Abrol N, et al. Simultaneous bilateral laparoscopic nephrectomy with kidney transplantation in patients with ESRD due to ADPKD: A single-center experience. American Journal of Transplantation. 2020; doi: 10.1111/ajt.16310.